To this end, GLP-1 is not produced in response to intravenous glucose and instead, the amount of GLP-1 released is relative to the size of a meal and is correlated to the rate of gastric emptying [29]
doi: 10.2337/diabetes.51.6.1779
There is currently no specific contraindication to using GLP-1 receptor agonists in people with Crohn's disease, but this decision requires careful individualised assessment
Acute drug effects in the CNS After single subcutaneous administration, GLP-1GIPLani and GLP-1GIP induced equal amounts of neuronal FOS activity in the arcuate nucleus, area postrema and nucleus tractus solitarius (Fig
Detailed clinical history and examination are crucial, determining which sites of the skin are affected by dermatitis and whether there are any systemic features, such as coughing, dyspnoea, and wheezing